Testing effectiveness (Phase 2)Study completedNCT00024089
What this trial is testing
Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 60